The global nuclear medicine market is set to expand from USD 10.41 billion in 2025 to USD 21.01 billion by 2030, boasting a ...

As theranostics adoption acceleratesi and radiopharmaceutical demand grows,ii healthcare systems are under increasing ...

A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who ...

A new first-in-human study has validated a PET radiotracer that can effectively image overactive adrenal glands, offering an ...

Nuclear medicine is being called a new frontier in cancer care, and new research shows potential new uses for it in treating gastric and pancreatic cancers.Nuclear medicine that uses radioactive ...

A novel PET radiotracer can accurately detect deep vein thrombosis in the legs and reveal whether clots have migrated to the ...

A novel PET imaging framework reveals that bariatric surgery impacts not only body weight, but also the metabolic function of ...

Doctors have used radioiodine therapy, a type of nuclear medicine treatment, since the 1940s. Now, a new generation of radiopharmaceuticals offers expanded treatment options for people with some types ...

A first-in-class PET imaging approach can accurately detect a biomarker for chronic traumatic encephalopathy (CTE), a ...

Rwanda turns to Russia for nuclear training and research, advancing ambitions in technology, healthcare and diplomacy.